Startup launches with $80M and a plan to teach the immune system to make better Tregsnews2025-10-28T11:00:34+00:00October 28th, 2025|Endpoints News|
Hemab nabs $157M to finance the ‘ultimate coagulation disorder’ biotechnews2025-10-27T10:00:58+00:00October 27th, 2025|Endpoints News|
Halda reveals first clinical data of RIPTAC drug in prostate cancernews2025-10-24T18:13:58+00:00October 24th, 2025|Endpoints News|
Philly is on Lilly’s radar for next Gateway Labs sitenews2025-10-24T17:20:51+00:00October 24th, 2025|Endpoints News|
Biogen pays $70M upfront to Vanqua Bio for immunology drugnews2025-10-24T14:29:40+00:00October 24th, 2025|Endpoints News|
Mikael Dolsten, Craig Crews team up for new molecular glue biotechnews2025-10-23T15:27:01+00:00October 23rd, 2025|Endpoints News|
Sanofi backs immunology startup, which raises $183M Series C for lead drug’s pivotal trialnews2025-10-22T11:00:41+00:00October 22nd, 2025|Endpoints News|
Elevara raises $70M to test a breast cancer approach in rheumatoid arthritisnews2025-10-21T23:01:30+00:00October 21st, 2025|Endpoints News|
Eli Lilly backs anti-aging biotech NewLimit in $45M raisenews2025-10-20T09:00:12+00:00October 20th, 2025|Endpoints News|
Exclusive: Sid Mukherjee’s Faeth nets $25M for endometrial cancer studynews2025-10-19T09:01:24+00:00October 19th, 2025|Endpoints News|
